22.12.2023 - REDWOOD CITY, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) - Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective December 20, 2023, the compensation committee of the Company’s board of directors granted ...